The Effect of Garcin® in Preventing AntiTB-Induced Hepatitis in Newly Diagnosed Tuberculosis Patients
| Author | Payam Tabarsi | en |
| Author | Fanak Fahimi | en |
| Author | Nader Heidarzadeh | en |
| Author | Roodabeh Haghgoo | en |
| Author | Mehdi Kazempour | en |
| Author | Mohammadreza Masjedi | en |
| Author | Ali Akbar Velayati | en |
| Issued Date | 2014-02-28 | en |
| Abstract | Adverse effects of antituberculosis agents such as hepatotoxicity may reduce treatment effectiveness, because they significantly contribute to nonadherence and eventually result in treatment failure, relapse or the emergence of drug resistance. Garlic is an ancient herbal substance, which its effectiveness on isoniazid and rifampicin-induced hepatic injury in animal models has been demonstrated (1). | en |
| DOI | https://doi.org/10.22037/ijpr.2014.1471 | en |
| URI | https://brieflands.com/journals/ijpr/articles/125429 | en |
| Keyword | Garlic | en |
| Keyword | Tuberculosis | en |
| Keyword | Drug-Induced hepatitis | en |
| Keyword | Clinical trial | en |
| Publisher | Brieflands | en |
| Title | The Effect of Garcin® in Preventing AntiTB-Induced Hepatitis in Newly Diagnosed Tuberculosis Patients | en |
| Type | Original Article | en |